On November 17, 2010
Acorda’s MS Drug Ampyra Looks Good Now, but That Probably Won’t Last
Acorda Therapeutics said usage among neurologists and insurers for its new MS drug Ampyra continued to grow in the third quarter. Contrary to management’s professed optimism, however, the question…
No tags for this post.
0 Comments